Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Fomivirsen
2. Fomivirsen Sodium
3. Isis 2922
4. Isis-2922
1. Fomivirsen Sodium
2. Isis-2922
3. Fomivirsen Sodium [usan]
4. Vitravene Preservative Free
5. Unii-3z6w3s36x5
6. 3z6w3s36x5
7. Drg-0234
8. Deoxyribonucleic Acid D(p-thio)(g-c-g-t-t-t-g-c-t-c-t-t-c-t-t-c-t-t-g-c-g), Eicosasodium Salt
| Molecular Weight | 7122 g/mol |
|---|---|
| Molecular Formula | C204H243N63Na20O114P20S20 |
| Hydrogen Bond Donor Count | 28 |
| Hydrogen Bond Acceptor Count | 144 |
| Rotatable Bond Count | 122 |
| Exact Mass | 7119.2341703 g/mol |
| Monoisotopic Mass | 7117.2274607 g/mol |
| Topological Polar Surface Area | 2940 Ų |
| Heavy Atom Count | 441 |
| Formal Charge | 0 |
| Complexity | 20200 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 63 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 21 |
For the local treatment of cytomegalovirus (CMV) retinitis in patients with acquired immuno-deficiency syndrome (AIDS).
Until further experience is gained, fomivirsen should be used only when other therapy has been ineffective or is considered unsuitable.
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Oligonucleotides, Antisense
Short fragments of DNA or RNA that are used to alter the function of target RNAs or DNAs to which they hybridize. (See all compounds classified as Oligonucleotides, Antisense.)
S01AD08
ABOUT THIS PAGE
64
PharmaCompass offers a list of Fomivirsen API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fomivirsen manufacturer or Fomivirsen supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fomivirsen manufacturer or Fomivirsen supplier.
PharmaCompass also assists you with knowing the Fomivirsen API Price utilized in the formulation of products. Fomivirsen API Price is not always fixed or binding as the Fomivirsen Price is obtained through a variety of data sources. The Fomivirsen Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fomivirsen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fomivirsen, including repackagers and relabelers. The FDA regulates Fomivirsen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fomivirsen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fomivirsen supplier is an individual or a company that provides Fomivirsen active pharmaceutical ingredient (API) or Fomivirsen finished formulations upon request. The Fomivirsen suppliers may include Fomivirsen API manufacturers, exporters, distributors and traders.
Fomivirsen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fomivirsen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fomivirsen GMP manufacturer or Fomivirsen GMP API supplier for your needs.
A Fomivirsen CoA (Certificate of Analysis) is a formal document that attests to Fomivirsen's compliance with Fomivirsen specifications and serves as a tool for batch-level quality control.
Fomivirsen CoA mostly includes findings from lab analyses of a specific batch. For each Fomivirsen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fomivirsen may be tested according to a variety of international standards, such as European Pharmacopoeia (Fomivirsen EP), Fomivirsen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fomivirsen USP).
